William C JR Bertrand
CIK 1291937 · Chief Operating Officer · last filed 2025-08-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.47M
Companies
6
Total Filings
46
Lifetime Open-Market Net
$43.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Chief Operating Officer | 986,352 | $0.06 | $57.1K | -$44.0K | 23 | 2025-08-29 |
| ARDX | Director | 290,707 | $5.69 | $1.65M | $100.0K | 13 | 2025-06-23 |
| ASND | Chief Operating Officer | 3,731 | $218.06 | $813.6K | -$12.2K | 3 | 2019-01-16 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | General Counsel | — | $0.04 | — | $0 | 1 | 2015-10-21 |
| SALIX PHARMACEUTICALS LTD (SLXP) Delisted | See Remarks | 31,258 | — | — | $0 | 2 | 2015-02-03 |
| MEDI | SVP, General Counsel, Sec | 0 | $31.04 | $0 | $0 | 3 | 2007-06-19 |
Recent Filings · Page 3 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-21 | ARDX | Grant (A) | +8,891 | $0 | EDGAR |
| 2021-01-12 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −2,234 | -$13.7K | EDGAR |
| 2021-01-11 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-05 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −3,499 | -$18.6K | EDGAR |
| 2020-12-15 | ARDX | Grant (A) | +15,000 | $106.3K | EDGAR |
| 2020-12-15 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Buy (P) | +207,000 | $143.8K | EDGAR |
| 2020-06-11 | ARDX | Grant (A) | +7,523 | $0 | EDGAR |
| 2020-01-17 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-15 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −2,397 | -$12.3K | EDGAR |
| 2020-01-07 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −3,731 | -$4.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.